Histotripsy: Innovations in Liver Tumor Management

Jospeh Herman, MD

Dr.

29d 18h 13m 18suntil start

Join link opens 10 minutes before the conference.

About This Conference

Histotripsy is an emerging non-invasive, non-thermal focused ultrasound technology that uses acoustic energy to mechanically destroy targeted liver tissue without the need for incisions, radiation, or thermal ablation. This innovative approach has shown promise in the treatment of primary and metastatic liver tumors, offering precise tissue destruction while preserving surrounding structures. This session will review the principles of histotripsy, current clinical applications, early outcomes in liver-directed therapy, and its potential role in the evolving multidisciplinary management of liver malignancies.

About the Speaker

Radiation Oncology

Joseph M. Herman, MD, MSc, MHCM is a nationally recognized radiation oncologist and leader in gastrointestinal cancer research. He currently serves as Medical Director at HistoSonics and is an Adjunct Professor at the Feinstein Institutes for Medical Research. Dr. Herman previously served as Director of Clinical Research for the Northwell Health Cancer Institute and held leadership positions at The University of Texas MD Anderson Cancer Center and Johns Hopkins University, where he co-founded and co-directed the multidisciplinary pancreatic cancer program. Dr. Herman has been actively involved in national guideline development through the National Comprehensive Cancer Network (NCCN) and the American College of Radiology (ACR), and has served on multiple national advisory boards and research initiatives focused on pancreatic and gastrointestinal cancers. His research has centered on innovative cancer therapies, including stereotactic body radiation therapy (SBRT), immunotherapy, and emerging non-invasive technologies such as histotripsy. He has authored hundreds of peer-reviewed publications and remains a leading advocate for multidisciplinary, patient-centered cancer care.